Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-588 (miR-588) is a small non-coding RNA molecule belonging to the microRNA family that post-transcriptionally regulates gene expression by binding to complementary sequences on target messenger RNAs, leading to their degradation or translational repression[2][7]. miR-588 has been implicated in the progression and metastasis of various cancers and can function either as a tumor suppressor or oncogene in a tissue-specific manner. In lung squamous cell carcinoma, gastric cancer, and glioma, miR-588 has been found to suppress tumor cell migration, invasion, and metastasis by directly targeting and downregulating genes such as progranulin (GRN) and roundabout guidance receptor 1 (ROBO1)[1][2][5]. Conversely, in certain contexts such as ovarian and prostate cancer, miR-588 may act as an oncogene and increase tumor cell proliferation and radioresistance[4][5]. The expression level of miR-588 is associated with patient prognosis in several cancer types, making it a potential prognostic biomarker. Due to its regulatory role in cancer cell behaviors, miR-588 is under investigation as a possible therapeutic target, though its context-specific effects necessitate careful consideration of tissue and disease state[1][2][4][5][7].
Gene silencing by binding to 3′ untranslated regions (3′UTR) of target mRNAs to downregulate protein expression (e.g., GRN, ROBO1, EIF5A2)[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-588 (miR-588).